Home  >  Products  >  JMJD3 (jumonji domain containing 3, histone lysine demethylase) Blocking Peptide (the N terminal of protein) (100ug)
JMJD3 (jumonji domain containing 3, histone lysine demethylase) Blocking Peptide (the N terminal of protein) (100ug)

JMJD3 (jumonji domain containing 3, histone lysine demethylase) Blocking Peptide (the N terminal of protein) (100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-JMJD3 antibody (Catalogue #: ARP40101_P050) made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Presku: AAP40101
Size: 100 ug
Weight: 181kDa
Gene: 23135
Format: Lyophilized powder
Target: JMJD3 is a histone demethylase that specifically demethylates 'Lys-27' of histone H3, thereby playing a central role in histone code. It plays a central role in regulation of posterior development, by regulating HOX gene expression. It is involved in inflammatory response by participating in macrophage differentiation in case of inflammation by regulating gene expression and macrophage differentiation.
Alternative names: KIAA0346
See Full Product Listings >